No Detail Found!

Comparative in vitro activity of selected antibacterial agents against Escherichia coli isolated from hospitalized patients suffering UTI

Author(s)
Farooq Ali Department of Microbiology, Hazara University,Mansehra,Pakistan
Saira Gul Department of Microbiology, Hazara University,Mansehra,Pakistan
Muhammad Shehryar Sabir Department of Microbiology, Hazara University,Mansehra,Pakistan
Qismat Shakeela Department of Microbiology, Abbottabad University of Science and Technology,Abbottabad,Pakistan
Atia Rasheed Department of Microbiology, University of Veterinary and Animal Sciences,Lahore,Pakistan
Farah Andleeb Department of Microbiology, Hazara University,Mansehra,Pakistan
Anwar Ullah Department of Microbiology, Hazara University,Mansehra,Pakistan
Saiqa Sardar Malaria Research Laboratory, Institute Oswaldo Cruz-Fiocruz,Rio de Janeiro,Brazil
Shehzad Ahmed Department of Microbiology, Hazara University,Mansehra,Pakistan
Abstract
Escherichia coli is the most studied among those bacteria causing urinary tract infections. This study was aimed to find out antibacterial activity and minimum inhibitory concentration of selected antibacterial agents against E. coli isolates of hospitalized UTI patients. The specimens were inoculated on Eosin Methylene Blue medium. E. coli isolates were identified via colonial morphology, biochemical testing and API-20 kit. The susceptibility pattern of antibacterial agents was determined applying disc diffusion method (Kirby-Bauer) and dilution tube method. Among all, 38.82% (n=158/407) specimens were positive for E. coli, while the rest showed either no growth or exhibited colonies other than E. coli. while observing the susceptibility pattern, Imipenem was found the most effective (73.42%) antibacterial agent, followed by nitrofurantoin (52.53%), cefpirome (44.94%) and tazobactam/ piperacillin (44.94%), whereas the E. coli isolates were highly resistant to sulfamethoxazole/trimethoprim (71.52%), followed by Amoxicillin-clavulanic acid (67.72%), nalidixic acid (66.46%) and Tobramycin (62.03%), when tested by disc diffusion method. The isolates were susceptible to cefpirome (39.87%) and tobramycin (39.87%) and resistant to sulfamethoxazole/trimethoprim (75.32%), followed by levofloxacin (61.39%), when tested by tube dilution method. The study concluded high degree of resistance against Sulfamethoxazole/trimethoprim, in contrast, cephalosporin and Imipenem exhibited good potency which can be recommended for UTI.
Publication Details
Page(s) 487-492
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 35, Issue: 2, Year: 2022

Request the full text from PASTIC

Keywords
UTI, MIC, coli, antibacterial agents, Susceptibility, E, tube dilution method
References
Adedeji B,Abdulkadir O B .2009 .Etiology and antimicrobial resistance pattern of bacterial agents of urinary tract infections in students of Tertiary institutions in Yola Metropolis. ABR, 3(1) : 67-70.
Ali F,Niaz Z,Shah PT,Shakeela Q,Uzma B,Ahmed S B .2020 .Antibiogram of Esbl And Mbl producing Pseudomonas aeruginosa among the population of Hazara division, KPK, Pakistan. , 70(11) : 1979-1984.
Ali F,Kamal S,Shakeela Q,Ahmed S Q .2021 .Extended-spectrum and Metallo-beta lactamase enzymes mediated resistance in Pseudomonas aeruginosa in clinically isolated specimens. KJS, 48(2) : 1-9.
Asl BH,Asghari R,Rezaee MA,Zadeh AM,Abri R .2017 .Evaluation of etiologic agents and antimicrobial resistance pattern of urinary tract infections in the northwest of Iran. J. Clin. Med. Res, 6(1) : 7-12.
Bashir M,Qazi J,Ahmad N,Riaz S N .2008 .Diversity of urinary tract pathogens and drug resistant isolates of Escherichia coli in different age and gender groups of Pakistanis. Trop J. Pharm. Res, 7(3) : 1025-1031.
Cars O,Hogberg LD,Murray M,Nordberg O,Sivaraman S,Lundborg CS,So AD,Tomson G .2008 .Meeting The Challenge of Antibiotic Resistance. , 337(1) : A1438.
Edlin RS,Shapiro Dj Fau - Hersh AL,Hersh Al Fau - Copp HL,Copp HL .2013 .Antibiotic resistance patterns of outpatient pediatric urinary tract infections. J. Urol, 190(1) : 222-227.
Farajnia S,Alikhani MY,Ghotaslou R,Naghili B,Nakhlband A .2009 .Causative agents and antimicrobial susceptibilities of urinary tract infections in the northwest of Iran. , 13(2) : 140-144.
Gharbi M,Drysdale JH,Lishman H,Goudie R,Molokhia M,Johnson AP,Holmes AH,Aylin P .2019 .Antibiotic management of urinary tract infection in elderly patients in primary care and its association with bloodstream infections and all cause mortality: Population based cohort study. BMJ., 2(12) : 364.
Gupta V,Datta P,Agnihotri N,Chander J .2006 .Comparative in vitro activities of seven new betalactams, alone and in combination with betalactamase inhibitors, against clinical isolates resistant to third generation cephalosporins. Braz. J. Infect. Dis, 10(1) : 22-25.
Hossain A,Hossain SA,Fatema AN,Wahab A,Alam MM,Islam MN,Hossain MZ,Ahsan GU .2020 .Age and gender-specific antibiotic resistance patterns among bangladeshi patients with urinary tract infection caused by Escherichia coli. Heliyon, 6(6) : E04161.
Joly-Guillou ML,Kempf M,Cavallo JD,Chomarat M,Dubreuil L,Maugein J,Muller-Serieys C,Roussel-Delvallez M .2010 .Comparative in vitro activity of meropenem, imipenem and piperacillin/ tazobactam against 1071 clinical isolates using 2 different methods: A French multicentre study. BMC Infect Dis, 10(1) : 1-9.
Khoshnood S,Heidary M,Mirnejad R,Bahramian A,Sedighi M,Mirzaei H M .2017 .Drug-resistant gram-negative uropathogens: A review. Biomed. Pharmacother, 94(1) : 982-994.
Kiffer CR,Kuti JL,Eagye KJ,Mendes C,Nicolau DP C .2006 .Pharmacodynamic profiling of imipenem, meropenem and ertapenem against clinical isolates of extended-spectrum β-lactamase-producing E. coli and Klebsiella spp. from Brazil. Int. J. Antimicrob. Agents, 28(4) : 340-344.
Livermore DM .2012 .Current epidemiology and growing resistance of gram-negative pathogens. The Korean J. Intern Med, 27(2) : 128.
Maillard JY .2018 .Resistance of bacteria to biocides. , 6(2) : 109-126.
Manikandan S,Ganesapandian S,Singh M,Kumaraguru A .2011 .Antimicrobial susceptibility pattern of urinary tract infection causing human pathogenic bacteria. Asian J. Med. Sci., 3(2) : 56-60.
Owuama CI .2017 .Determination of minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) using a novel dilution tube method. Afr. J. Microbiol. Res., 11(23) : 977-980.
Kozlov Oxford J,R Oxford J .2013 .Antibiotic resistance-a call to arms for primary healthcare providers. Int. J. Clin. Pract, 67 : 1-3.
Prakasam A,Kumar KD,Vijayan M .2012 .A cross sectional study on distribution of urinary tract infection and their antibiotic utilisation pattern in Kerala. Int. J. Pharmtech. Res., 4(3) : 1310-1316.
Sharma AR,Bhatta DR,Shrestha J,Banjara MR .2013 .Antimicrobial susceptibility pattern of escherichia coli isolated from urinary tract infected patients attending bir hospital. Nepal J. Sci. Technol, 14(1) : 177-184.
Sirot J,Nicolas‐Chanoine M,Chardon H,Avril J,Cattoen C,Croix J,Dabernat H,Fosse T,Ghnassia J,Lecaillon E .2002 .Susceptibility of enterobacteriaceae to β-lactam agents and fluoroquinolones: A 3-year survey in France. , 8(4) : 207-213.
Solomon FB,Wadilo FW,Arota AA,Abraham YL .2017 .Antibiotic resistant airborne bacteria and their multidrug resistance pattern at University Teaching Referral Hospital in south Ethiopia. , 16(1) : 29.
Tansarli GS,Athanasiou S,Falagas ME .2013 .Antimicrobial susceptibility of enterobacteriaceae causing urinary tract infections in africa: evaluation of the evidence. Antimicrob, 57(8) : 00359-13.
Tanvir R,Hafeez R,Hasnain S R .2012 .Prevalence of multiple drug resistant Escherichia coli in patients of urinary tract infection registering at a diagnostic laboratory in Lahore Pakistan. , 44(3) : 707-12.
Wayne P .2011 .Performance standards for antimicrobial susceptibility testing. Inform Suppl, 31(1) : 100-121.
Zalewska-Piątek BM,Piątek RJ .2019 .Alternative treatment approaches of urinary tract infections caused by uropathogenic Escherichia coli strainsreview. Acta Biochim. Pol., 66(2) : 129-138.
0

Citations

0

Downloads

89

Views